Calendar

Cloudflare’s reported Q2 2026 revenue growth and a $736.8M Q3 revenue consensus provide a credible business backdrop, but the stock fell sharply into the event: it lost roughly 15.5% from Oct. 26 to Oct. 30, including a high-volume down day. Required positive tape and estimate-upside signals are not supported.

ABNB has a small positive whisper-versus-consensus gap and recent company guidance describes strong revenue growth, but the guidance midpoint is slightly below the checked revenue consensus. The stock fell about 4.4% over five sessions, had no close above the 0.75 close-location threshold in the latest three sessions, and no confirmed 1.5x volume session; it does not qualify despite a supportive XLY tape.

EOG has upward EPS estimate revisions, a credible Q3 consensus, and a strong Oct. 30 close, but available checks did not establish positive revenue revisions or a recent >1.5x-volume accumulation day. The company has scheduled its Q3 results for Nov. 5 after close; its IR page separately lists a Nov. 6 results call.

Lumentum's September-quarter EPS estimate rose from $4.21 to $4.22 over the last month, and its prior company guidance midpoint for $1.25B revenue is in line with reported consensus; management cited accelerating AI-driven optical demand and the stock advanced sharply over the preceding five sessions. However, the late-week reversal and lack of a verified normal-volume comparator temper the setup, while valuation and execution risks remain material.

Simon has positive, though non-uniform, estimate momentum: checked consensus showed EPS up 1.74% and revenue up 3.69% over three months, and its latest reported quarter showed 96.0% occupancy, higher retailer sales, and raised full-year FFO guidance. The stock gained about 2.4% over five sessions and closed near the top of its Oct 30 range, but a normal-volume comparison was unavailable and its recent earnings history is uneven.

DVN has positive near-term estimate revisions, rising revenue expectations, four recent EPS beats per Zacks, and an official Nov. 5 reporting date; the stock also strengthened into the event. However, earnings-whisper EPS is below some consensus figures and the shares lagged the energy sector over the past month, while commodity exposure and transaction execution leave meaningful uncertainty.

Earnings Whispers reports a $1.48 whisper against $1.39 consensus, while the prior quarter had strong reported growth; however, no reliable pre-event revenue-revision, verified close-location, or volume-accumulation evidence was found for this screen, and the supplied latest close does not establish recent strength. The positive whisper alone is insufficient for qualification.

ED's reported date and consensus figures were available, and the recent close rose with XLU supportive; Con Edison had reaffirmed its 2026 adjusted EPS guidance. But no positive EPS revision, ESP, whisper, or revenue-upside signal was verified, and none of the last three checked sessions closed in the upper quarter of its range.

A pre-event Zacks article says the estimate-revision combination points toward a likely EPS beat, and recent annualized recovery expectations offer a possible cyclical catalyst. However, exact revision and current-quarter revenue consensus/upside evidence was not verifiable in the checked results, while Oct. 30 brought a high-volume 4.66% selloff and a weak close; it fails the required tape confirmation.

Live Nation has strong operating indicators ahead of the report: the latest available filing said 2026 event ticket sales were pacing 11% higher and deferred revenue reached a second-quarter record, while the stock recovered into Oct. 30 on a large-volume up day. But current-quarter revenue consensus estimates varied across checked providers and no positive EPS revision/ESP/whisper was verified; score remains below the required threshold.

The supplied Nov. 5 date conflicts with checked earnings sources: Earnings Whispers and MarketBeat indicate Nov. 4, while another estimate page shows Nov. 5 and cautions the date may move. Consensus estimates exist, but no positive revisions or required tape confirmation were established; reject on unconfirmed event date and incomplete signals.

MRNA has a modestly favorable EPS revision snapshot and a recent high-volume rebound, but the checked calendar sources describe Nov. 6 as estimated rather than company-confirmed, and no positive revenue revision or upside indicator was verified. The Oct. 22 melanoma-trial data leak coincided with a 17.57% drop and unusually high volume, leaving a volatile, event-driven tape.

Record Q2 fundraising and 20% fee-related-earnings growth, alongside a rising recent share price and several analyst target cuts, create a constructive but mixed backdrop. The checked sources support EPS and revenue consensus, but do not establish positive estimate revisions or an upside surprise signal; recent volume also falls short of a verified accumulation trigger.

Humana's primary IR estimate table showed near-flat Q3 EPS revisions and a credible consensus source provides EPS and revenue estimates, but the stock weakened into the event and underperformed the rising XLV. Medical-cost and Medicare policy uncertainty remain material, while recent tape did not confirm accumulation.

Vistra has a company-confirmed Nov. 6 report date and a strongly positive 30-day Q3 EPS revision, alongside long-term power-demand catalysts. However, shares declined about 5.4% from Oct. 26 through Oct. 30, recent closes were weak in their daily ranges, and the latest quarter missed consensus materially. Positive revisions alone do not offset the poor pre-event tape and limited recent execution evidence.

The packet's $7.23 October 16 close was up about 8.2% from October 15, according to [historical prices](https://chartexchange.com/symbol/nasdaq-aloy/historical/), but no confirmed Q3 release links that move to earnings. No post-print analyst revisions were verified. Sentiment metrics other than low observed headline buzz are unavailable; zero entries above denote unavailable data, not measured neutral readings. Compared with the April baseline, funding and project detail improved, but this T+1 earnings follow-up remains tentative.

The company-confirmed beat contrasts with a negative market response: $186.64 on October 13 to $181.51 on release day and $180.57 on October 16, a 3.25% cumulative decline. Several analysts reduced targets after the print, although cited ratings were largely maintained; a comprehensive forward-estimate revision series and companywide quantitative guidance were unavailable. The neutral deterministic prior and sizable thesis-change score support resetting April's positive baseline to cautious monitoring rather than treating the beat as a fresh bullish catalyst. Sentiment numeric zeros are unavailable-data placeholders, not measured neutral readings; no sufficient social, options, short-interest or employee-score coverage was supplied. [Closing prices](https://chartexchange.com/symbol/nyse-ms/historical/); [analyst changes](https://www.benzinga.com/analyst-stock-ratings/price-target/26/10/62388622/morgan-stanley-analysts-cut-their-forecasts-after-q3-results).

Tone is mixed-positive rather than unqualified bullish: the stock rose from a reported $28.29 October 14 close to the packet's $29.20 October 16 anchor, about 3.2%, but the revenue miss and falling loans complicate attribution of that move solely to earnings. Piper's target cut and Cantor's target increase show divergent post-print revisions; broader estimate-revision coverage is unavailable. Social, options, short-interest and employee measures were not supplied, so their numeric sentiment fields are unavailable rather than observed zero. [October 14 historical close](https://www.stockmonitor.com/quote/homb/) [Piper revision coverage](https://ca.investing.com/news/stock-market-news/piper-sandler-lowers-home-bancshares-price-target-to-34-on-growth-93CH-4885468) [Cantor target record](https://www.benzinga.com/quote/HOMB/price-targets)

The print drew mixed coverage: EPS beat the cited $0.34 estimate, but revenue-surprise comparisons conflict across providers. Shares closed at $52.00 on October 14, $50.38 on October 15 and the packet's $51.02 anchor on October 16, indicating an initially volatile reaction rather than a sustained breakout. Post-print target raises are confirmed, but forward-estimate changes are not. Zero-valued sentiment fields denote unavailable measurements, not neutral readings. [#SEC-8K-2026-10-14] [Historical prices](https://stockanalysis.com/stocks/fast/history/) [Benzinga](https://www.benzinga.com/news/26/10/62380992/these-analysts-boost-their-forecasts-on-fastenal-after-q3-results)

The October 16 anchor is $55.69, but no verified post-third-quarter-release price reaction exists. The stored October 15 item is a Zacks pre-report estimates article, not a company release or reported result; its small downward EPS-consensus revision predates any print. The company investor-relations review and bounded SEC search did not establish a third-quarter release, while an external calendar labels October 20 an estimate rather than a company-confirmed date. Post-print analyst revisions and target changes therefore remain unavailable. Sentiment fields set to zero denote unavailable measurements, not neutral observations. The deterministic prior is neutral, and the date mismatch keeps this a tentative monitoring view. [Commerce investor relations](https://investor.commercebank.com/news-info/financial-news-releases/default.aspx) [MarketBeat estimated calendar](https://www.marketbeat.com/earnings/reports/2026-10-20-commerce-bancshares-inc-stock/)

No confirmed October 14 earnings release was found, so there is no defensible post-print surprise, guidance revision, or earnings-linked price reaction to report. The $25.75 anchor is dated October 16, not a verified reaction to results. StoneX's September initiation predates the supposed print, and post-print analyst revisions are unavailable. Sentiment metrics other than low observed headline activity were not supplied; zero values denote unavailable data, not neutral readings. [Company IR](https://ir.communitywestbank.com/news/default.aspx)